Induction of p53-Dependent G1 Cell Cycle Arrest by Rhus verniciflua. Stokes Extract in Human Breast Carcinoma MCF-7 Cells |
Hong, Sang-hoon
(Dept. of Korean Internal Medicine, College of Korean Medicine, Dong-Eui University)
Han, Min-ho (Dept. of Biochemistry, College of Korean Medicine, Dong-Eui University) Choi, Yung-hyun (Dept. of Biochemistry, College of Korean Medicine, Dong-Eui University) Park, Sang-eun (Dept. of Korean Internal Medicine, College of Korean Medicine, Dong-Eui University) |
1 | Wesierska-Gadek J, Krystof V. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia? Ann N Y Acad Sci 2009;1171 :228-41. DOI ScienceOn |
2 | Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60(14):3689-95. |
3 | Morgan DO. Principles of CDK regulation. Nature 1995;374(6518):131-4. DOI |
4 | Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602(1):73-87. |
5 | Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996;8(6):805-14. DOI |
6 | Helmbold H, Galderisi U, Bohn W. The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence. J Cell Physiol 2012; 227(2):508-13. DOI |
7 | Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67(6):1169-79. DOI |
8 | Brandeis M, Hunt T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosi until the onset of S phase. EMBO J 1996;15(19):5280-9. |
9 | Markers M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006;18(4) :CD005001. |
10 | Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;19(1):CD001877. |
11 | Lee KS, Shin JS, Nam KS. Cancer chemopreventive effects of starfish polysaccharide in human breast cancer cell. Biotechnol Bioprocess eng 2011;16(5) :987-91. DOI |
12 | Fairey AS, Courneya KS, Field CJ, Mackey JR. Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 2002;94(2):539-51. DOI |
13 | 송미선, 김윤상, 임은미. 건칠에 대한 문헌적 고찰. 대한한방부인과학회지 2002;15(1):61-76. |
14 | Levine AJ, Hu W, Feng Z. P53 pathway: what questions remain to be explored? Cell Death Differ 2006;13(6):1027-36. DOI |
15 | Vargas DA, Takahashi S, Ronai Z. Mdm2: A regulator of cell growth and death. Adv Cancer Res 2003;89:1-34. DOI |
16 | Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285(5434):1733-7. DOI |
17 | 국가암정보센터: 암통계, 2014. |
18 | Kalles V, Zografos GC, Provatopoulou X, Koulocheri D, Gounaris A. The current status of position emission mammography in brest cancer diagnosis. Breast Cancer 2013;20(2):123-30. DOI ScienceOn |
19 | 이준성, 유동열. 건칠산 전탕액이 여성암 세포주에 미치는 영향. 대한한방부인과학회지 1997; 10(2):201-21. |
20 | 안진영, 고성규, 고흥. 건칠(乾漆)이 위암세포의 활성, 세포사멸 및 세포주기관련 유전자 발현에 미치는 영향. 동의생리병리학회지 2006;20(3) :701-9. |
21 | 윤성우, 박재우, 김경석, 정현식, 최원철. 건칠추출물(Nexia)의 독성 실험과 금성림프구성 백혈병환자의 임상증례군. 대한암한의학회지 2007;11(1) :1-21. |
22 | Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003;13(2):65-70. DOI |
23 | Elledge SJ, Harper JW. Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 1994;6(6):847-52. DOI |
24 | Lee JO, Moo JW, Kim SM, Kim N, Ko SG, Kim HS, et al. Rhus verniciflua extract modulates survival of MCF-7 breast cancer cells through the modulation of AMPK-pathway. Biol pharm Bull 2014;37(5):794-801. DOI |
25 | 최진영, 박재우, 김경석, 최원철, 윤성우. 알러젠 제거 옻나무추출물 투여로 호전된 편도선암 환자 1례. 대한암한의학회지 2007;12(1):91-7. |
26 | 김초영, 박재우, 정현식, 최원철, 윤성우. 알러젠 제거 옻나무추출물 투여로 호전된 유방암 환자 1례. 대한암한의학회지 2007;12(1):67-73. |